C-aryl glycoside compounds for the treatment of diabetes and...

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 7/04 (2006.01) A61K 8/60 (2006.01) A61K 8/69 (2006.01) A61K 31/7034 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 7/00 (2006.01) A61P 9/10 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) A61Q 19/02 (2006.01) C07D 309/10 (2006.01) C07H 7/06 (2006.01) C07H 15/18 (2006.01)

Patent

CA 2720011

This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt there of, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers, and partic-ularly a racemate mixture, in particular for use thereof as a drug, notably in the treatment of diabetes.

Cette invention porte sur un composé de formule générique (I) : (I) ainsi que sur un sel pharmaceutiquement acceptable de celui-ci, un tautomère, un isomère optique ou un mélange d'isomères optiques dans toute proportion, en particulier un mélange d'énantiomères, et particulièrement un mélange racémate, en particulier en vue de leur utilisation en tant que médicament, notamment dans le traitement du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

C-aryl glycoside compounds for the treatment of diabetes and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-aryl glycoside compounds for the treatment of diabetes and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-aryl glycoside compounds for the treatment of diabetes and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1980187

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.